Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer K Smith

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|June 19, 2018
Experimental Infection of Syrian Hamsters With Aerosolized Nipah VirusOlivier Escaffre, Terence Hill, Tetsuro Ikegami, et al.
Viruses|July 27, 2024
Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus DiseaseDylan M Johnson, Terry Juelich, Lihong Zhang, et al.
Plos One|December 22, 2017
Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse modelTetsuro Ikegami, Aaron Balogh, Shoko Nishiyama, et al.
Journal of Virology|August 2, 2013
Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virusNadezhda E Yun, Alexey V Seregin, David H Walker, et al.
Plos Biology|February 29, 2024
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replicationCarlos A Rodríguez-Salazar, Sarah van Tol, Olivier Mailhot, et al.
Vaccine|August 6, 2009
Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellinLangzhou Song, Yi Zhang, Nadezhda E Yun, et al.
Plos Pathogens|April 3, 2026
Efficacy of the nucleoside analog 4'-Fluorouridine against Nipah virus in the Syrian hamster modelOlivier Escaffre, Madison L Pearson, Terry L Juelich, et al.
Science Translational Medicine|June 10, 2026
A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralizationAxel A Guzmán-Solís, Mohamed Ouizougun-Oubari, Olivier Escaffre, et al.
Plos Pathogens|May 3, 2013
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionFrederic Vigant, Jihye Lee, Axel Hollmann, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Furin Cleavage Site Is Key to SARS-CoV-2 PathogenesisBryan A Johnson, Xuping Xie, Birte Kalveram, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|June 19, 2018
Experimental Infection of Syrian Hamsters With Aerosolized Nipah VirusOlivier Escaffre, Terence Hill, Tetsuro Ikegami, et al.
Viruses|July 27, 2024
Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus DiseaseDylan M Johnson, Terry Juelich, Lihong Zhang, et al.
Plos One|December 22, 2017
Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse modelTetsuro Ikegami, Aaron Balogh, Shoko Nishiyama, et al.
Journal of Virology|August 2, 2013
Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virusNadezhda E Yun, Alexey V Seregin, David H Walker, et al.
Plos Biology|February 29, 2024
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replicationCarlos A Rodríguez-Salazar, Sarah van Tol, Olivier Mailhot, et al.
Vaccine|August 6, 2009
Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellinLangzhou Song, Yi Zhang, Nadezhda E Yun, et al.
Plos Pathogens|April 3, 2026
Efficacy of the nucleoside analog 4'-Fluorouridine against Nipah virus in the Syrian hamster modelOlivier Escaffre, Madison L Pearson, Terry L Juelich, et al.
Science Translational Medicine|June 10, 2026
A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralizationAxel A Guzmán-Solís, Mohamed Ouizougun-Oubari, Olivier Escaffre, et al.
Plos Pathogens|May 3, 2013
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionFrederic Vigant, Jihye Lee, Axel Hollmann, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Furin Cleavage Site Is Key to SARS-CoV-2 PathogenesisBryan A Johnson, Xuping Xie, Birte Kalveram, et al.
Pageof 6